Cargando…

Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme

BACKGROUND: Hypertension and/or myocardial infarction are common causes of heart failure in Type 2 diabetes. Progression to heart failure is usually preceded by ventricular dysfunction, linked to matrix metalloproteinase (MMP) mediated extracellular matrix changes. We hypothesise that the minor alle...

Descripción completa

Detalles Bibliográficos
Autores principales: Watson, Chris, Spiers, J. Paul, Waterstone, Max, Russell-Hallinan, Adam, Gallagher, Joseph, McDonald, Kenneth, Ryan, Cristin, Gilmer, John, Ledwidge, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879511/
https://www.ncbi.nlm.nih.gov/pubmed/33579197
http://dx.doi.org/10.1186/s12872-021-01860-7
_version_ 1783650530068791296
author Watson, Chris
Spiers, J. Paul
Waterstone, Max
Russell-Hallinan, Adam
Gallagher, Joseph
McDonald, Kenneth
Ryan, Cristin
Gilmer, John
Ledwidge, Mark
author_facet Watson, Chris
Spiers, J. Paul
Waterstone, Max
Russell-Hallinan, Adam
Gallagher, Joseph
McDonald, Kenneth
Ryan, Cristin
Gilmer, John
Ledwidge, Mark
author_sort Watson, Chris
collection PubMed
description BACKGROUND: Hypertension and/or myocardial infarction are common causes of heart failure in Type 2 diabetes. Progression to heart failure is usually preceded by ventricular dysfunction, linked to matrix metalloproteinase (MMP) mediated extracellular matrix changes. We hypothesise that the minor allele of genetic variant rs3918242 in the promoter region of the MMP-9 gene is associated with hypertension and/or myocardial infarction, with resultant progression of dysfunctional cardiac remodelling in patients with diabetes without symptomatic heart failure. METHODS: We genotyped 498 diabetes patients participating in the St Vincent’s Screening TO Prevent Heart Failure (STOP-HF) follow-up programme for the rs3918242 single nucleotide polymorphism and investigated associations with the co-primary endpoints hypertension and/or myocardial infarction using a dominant model. We also evaluated resulting cardiometabolic phenotype and progression of ventricular dysfunction and cardiac structural abnormalities over a median follow-up period of 3.5 years. RESULTS: The CT/TT genotype comprised 28.1% of the cohort and was associated with a twofold higher risk of myocardial infarction (17.9% vs 8.4%), a reduction in ejection fraction and greater left ventricular systolic dysfunction progression [adjusted OR = 2.56 (1.09, 6.01), p = 0.026] over a median follow-up of 3.5 years [IQR 2.6, 4.9 years]. Conversely, rs3918242 was not associated with hypertension, blood pressure, pulse pressure or left ventricular mass index at baseline or over follow up. CONCLUSIONS: Diabetes patients with the minor T allele of rs3918242 in the STOP-HF follow up programme have greater risk of myocardial infarction, lower ejection fraction and greater progression of left ventricular systolic abnormalities, a precursor to heart failure. These data may support further work on MMP-9 as a biomarker of ventricular dysfunction and the investigation of MMP-9 inhibitors for heart failure prevention in diabetes, particularly in the post-infarction setting. ClinicalTrials.gov Identifier: NCT00921960
format Online
Article
Text
id pubmed-7879511
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78795112021-02-17 Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme Watson, Chris Spiers, J. Paul Waterstone, Max Russell-Hallinan, Adam Gallagher, Joseph McDonald, Kenneth Ryan, Cristin Gilmer, John Ledwidge, Mark BMC Cardiovasc Disord Research Article BACKGROUND: Hypertension and/or myocardial infarction are common causes of heart failure in Type 2 diabetes. Progression to heart failure is usually preceded by ventricular dysfunction, linked to matrix metalloproteinase (MMP) mediated extracellular matrix changes. We hypothesise that the minor allele of genetic variant rs3918242 in the promoter region of the MMP-9 gene is associated with hypertension and/or myocardial infarction, with resultant progression of dysfunctional cardiac remodelling in patients with diabetes without symptomatic heart failure. METHODS: We genotyped 498 diabetes patients participating in the St Vincent’s Screening TO Prevent Heart Failure (STOP-HF) follow-up programme for the rs3918242 single nucleotide polymorphism and investigated associations with the co-primary endpoints hypertension and/or myocardial infarction using a dominant model. We also evaluated resulting cardiometabolic phenotype and progression of ventricular dysfunction and cardiac structural abnormalities over a median follow-up period of 3.5 years. RESULTS: The CT/TT genotype comprised 28.1% of the cohort and was associated with a twofold higher risk of myocardial infarction (17.9% vs 8.4%), a reduction in ejection fraction and greater left ventricular systolic dysfunction progression [adjusted OR = 2.56 (1.09, 6.01), p = 0.026] over a median follow-up of 3.5 years [IQR 2.6, 4.9 years]. Conversely, rs3918242 was not associated with hypertension, blood pressure, pulse pressure or left ventricular mass index at baseline or over follow up. CONCLUSIONS: Diabetes patients with the minor T allele of rs3918242 in the STOP-HF follow up programme have greater risk of myocardial infarction, lower ejection fraction and greater progression of left ventricular systolic abnormalities, a precursor to heart failure. These data may support further work on MMP-9 as a biomarker of ventricular dysfunction and the investigation of MMP-9 inhibitors for heart failure prevention in diabetes, particularly in the post-infarction setting. ClinicalTrials.gov Identifier: NCT00921960 BioMed Central 2021-02-12 /pmc/articles/PMC7879511/ /pubmed/33579197 http://dx.doi.org/10.1186/s12872-021-01860-7 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Watson, Chris
Spiers, J. Paul
Waterstone, Max
Russell-Hallinan, Adam
Gallagher, Joseph
McDonald, Kenneth
Ryan, Cristin
Gilmer, John
Ledwidge, Mark
Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme
title Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme
title_full Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme
title_fullStr Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme
title_full_unstemmed Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme
title_short Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme
title_sort investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in irish caucasian patients with diabetes: a report from the stop-hf follow-up programme
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879511/
https://www.ncbi.nlm.nih.gov/pubmed/33579197
http://dx.doi.org/10.1186/s12872-021-01860-7
work_keys_str_mv AT watsonchris investigationofassociationofgeneticvariantrs3918242ofmatrixmetalloproteinase9withhypertensionmyocardialinfarctionandprogressionofventriculardysfunctioninirishcaucasianpatientswithdiabetesareportfromthestophffollowupprogramme
AT spiersjpaul investigationofassociationofgeneticvariantrs3918242ofmatrixmetalloproteinase9withhypertensionmyocardialinfarctionandprogressionofventriculardysfunctioninirishcaucasianpatientswithdiabetesareportfromthestophffollowupprogramme
AT waterstonemax investigationofassociationofgeneticvariantrs3918242ofmatrixmetalloproteinase9withhypertensionmyocardialinfarctionandprogressionofventriculardysfunctioninirishcaucasianpatientswithdiabetesareportfromthestophffollowupprogramme
AT russellhallinanadam investigationofassociationofgeneticvariantrs3918242ofmatrixmetalloproteinase9withhypertensionmyocardialinfarctionandprogressionofventriculardysfunctioninirishcaucasianpatientswithdiabetesareportfromthestophffollowupprogramme
AT gallagherjoseph investigationofassociationofgeneticvariantrs3918242ofmatrixmetalloproteinase9withhypertensionmyocardialinfarctionandprogressionofventriculardysfunctioninirishcaucasianpatientswithdiabetesareportfromthestophffollowupprogramme
AT mcdonaldkenneth investigationofassociationofgeneticvariantrs3918242ofmatrixmetalloproteinase9withhypertensionmyocardialinfarctionandprogressionofventriculardysfunctioninirishcaucasianpatientswithdiabetesareportfromthestophffollowupprogramme
AT ryancristin investigationofassociationofgeneticvariantrs3918242ofmatrixmetalloproteinase9withhypertensionmyocardialinfarctionandprogressionofventriculardysfunctioninirishcaucasianpatientswithdiabetesareportfromthestophffollowupprogramme
AT gilmerjohn investigationofassociationofgeneticvariantrs3918242ofmatrixmetalloproteinase9withhypertensionmyocardialinfarctionandprogressionofventriculardysfunctioninirishcaucasianpatientswithdiabetesareportfromthestophffollowupprogramme
AT ledwidgemark investigationofassociationofgeneticvariantrs3918242ofmatrixmetalloproteinase9withhypertensionmyocardialinfarctionandprogressionofventriculardysfunctioninirishcaucasianpatientswithdiabetesareportfromthestophffollowupprogramme